Archive for July, 2018


Lymphocytes cells

Ask an expert at Drug Discovery 2018: the latest advances in PROTAC technology

  If you’re working in cancer drug discovery, it’s no secret that proteolysis targeting chimeras (PROTACs) hold great promise for developing innovative new treatments. We’ve seen that these bifunctional molecules can remove unwanted proteins by inducing selective intracellular proteolysis, making them potentially applicable in several areas of oncology. But despite all this burgeoning potential, the

Read More